FDA OKs convalescent plasma as COVID--19 treatment
The FDA concludes that convalescent plasma may be effective in treating COVID-19 and that the known and potential benefits outweigh the known and potential risks.
The FDA concludes that convalescent plasma may be effective in treating COVID-19 and that the known and potential benefits outweigh the known and potential risks.